Denali Capital extends business combination deadline to April 11 via $15K trust deposit

Semnur Pharmaceuticals, Inc.

Deposited $15,063.74 into trust to extend deadline from March 11 to April 11, 2025.
Funding via convertible promissory note from Scilex (SCLX) with principal up to $180,000.
Note bears no interest, convertible into Class A shares at $10.00 per share upon closing.
Remaining $59,545.08 under note available for future one-month extensions.
Company is a blank check SPAC seeking a merger or acquisition.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.